Your browser doesn't support javascript.
loading
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
Jiang, Baishan; Weinstock, David M; Donovan, Katherine A; Sun, Hong-Wei; Wolfe, Ashley; Amaka, Sam; Donaldson, Nicholas L; Wu, Gongwei; Jiang, Yuan; Wilcox, Ryan A; Fischer, Eric S; Gray, Nathanael S; Wu, Wenchao.
Afiliação
  • Jiang B; Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
  • Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA.
  • Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Sun HW; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital, Jinan University, Zhuhai, China.
  • Wolfe A; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Amaka S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Donaldson NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Wu G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Jiang Y; Department of Radiation and Medical Oncology, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
  • Wilcox RA; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
  • Gray NS; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: nsgray01@stanford.edu.
  • Wu W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address: wuwch@sysucc.org.cn.
Cell Chem Biol ; 30(4): 383-393.e6, 2023 04 20.
Article em En | MEDLINE | ID: mdl-37015223
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Linfoma de Células T Limite: Humans Idioma: En Revista: Cell Chem Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Linfoma de Células T Limite: Humans Idioma: En Revista: Cell Chem Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos